← FDA Drug Approvals (Drugs@FDA)
TOFACITINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMS INC · Approved 2023-01-06
Drug application
- FDA Application #
ANDA217299- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TOFACITINIB
- Generic name
- Tofacitinib Citrate
- Active ingredients
- TOFACITINIB CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN PHARMS INC
- First approval
- 2023-01-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown